about
Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damageCurrent and emerging biomarkers of cell death in human disease.Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal CellsTargeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic SteatohepatitisHypothermic Oxygenated Liver Perfusion: Basic Mechanisms and Clinical ApplicationElevation of Alanine Aminotransferase Activity Occurs after Activation of the Cell-Death Signaling Initiated by Pattern-Recognition Receptors but before Activation of Cytolytic Effectors in NK or CD8+ T Cells in the Liver During Acute HCV InfectionCellular and molecular etiology of hepatocyte injury in a murine model of environmentally induced liver abnormalityCorrelation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease.Noninvasive Imaging of Stored Red Blood Cell-Transfusion Aggravating Sepsis-Induced Liver Injury Associated with Increased Activation of M1-Polarized Kupffer CellsSerum MicroRNAs Reflect Injury Severity in a Large Animal Model of Thoracic Spinal Cord InjuryIdentification of protein tyrosine phosphatase receptor gamma extracellular domain (sPTPRG) as a natural soluble protein in plasma.Arrhythmia risk in liver cirrhosis.Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosisCigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's DiseaseCell death and cell death responses in liver disease: mechanisms and clinical relevanceEpigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET ProteinsMolecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.Mechanism of Hepatocyte Apoptosis.Toxicogenomic module associations with pathogenesis: a network-based approach to understanding drug toxicity.White Adipose Tissue Browning: A Double-edged Sword.Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury.Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferationViral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.Decreased serum DNase1-activity in patients with autoimmune liver diseases.M2-like macrophages in the fibrotic liver protect mice against lethal insults through conferring apoptosis resistance to hepatocytes.Changes in microRNA expression during disease progression in patients with chronic viral hepatitis.CSH guidelines for the diagnosis and treatment of drug-induced liver injurySerum Cytokeratin-18 Levels for Liver Fibrosis PredictionThe liver protection of propylene glycol alginate sodium sulfate preconditioning against ischemia reperfusion injury: focusing MAPK pathway activity.Transfusion Decision Making in Pediatric Critical Illness.SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease.A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis.Novel Protective Role of Nicotinamide Phosphoribosyltransferase in Acetaminophen-Induced Acute Liver Injury in Mice.Interactions of Gut Microbiota, Endotoxemia, Immune Function, and Diet in Exertional Heatstroke.131I-Evans blue: evaluation of necrosis targeting property and preliminary assessment of the mechanism in animal models.Beyond KCH selection and options in acute liver failure.A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis
P2860
Q26773289-59321B97-CD09-46DD-B282-C69233C6D720Q27690667-E7537065-586E-47E8-BF41-68A34AA14D86Q28071596-E79E1DB9-8F24-446F-A077-7ACF673FE4EBQ28077079-4B608ABB-BF35-4DB0-9D85-705E8B29339AQ28085288-FE9F3A00-B56F-48E1-891E-2634237C2720Q28553005-2C1BFEFF-6757-4ADB-9A9B-FE51AA080CD9Q28821067-EED7A68F-CC43-4F2C-9EC1-C7BFA3D2B48EQ30355958-5F9B1AAE-D2B9-4F5C-A6BB-148A77295BABQ30491207-34F335AB-CF26-48B8-85C1-5E04EB9151B9Q33684070-FEF0720A-64A8-4DFD-A645-C8384CCBC995Q35182285-1AEBF46A-B5AD-49BB-916D-742D2D328C10Q35308671-7FC5E99E-CEA6-4724-BB09-5BAD5885EED7Q35674098-FA303474-7B69-4DDB-8657-1A1C41E1002DQ35912013-E4571246-9404-4A3F-9105-33630BDDC939Q35938040-10CF47C8-4D80-4FE2-8054-728EB1AC3DFCQ36194904-B893B884-740C-4A21-8A62-368DBAA7296CQ37062751-CCB49748-879C-4B05-8E40-9EFEA0B8425EQ38725581-8106D4D3-82BF-4D9C-9A00-C2F972A10571Q38774266-5BCAD245-3170-4C1E-8D13-DC33DFF00063Q38821270-20E73814-E45A-4741-81F8-F6790CC85B6BQ38891681-80FAFA24-77CF-439F-80D6-9022E8F79F3CQ39059921-71019654-6A07-45EB-B318-E25F32C20229Q39743133-6FE5F720-4959-4212-94D6-434E43219D31Q40066224-5F3A6E9A-1B17-4067-9EB4-89CA9246E453Q40306774-09352D9B-F605-4596-A1DC-815701CAB120Q41620915-2343AE81-1D18-4A64-9F36-A6384199CE37Q42180884-0B4156D5-AAA6-455F-8D73-48381AB63C59Q42354312-82F5277A-E345-4E72-8A01-4077FA8CC364Q42754440-6637B34C-54D7-4361-BB84-005DA68B880FQ44481217-BEADD8AB-9356-4650-9F49-C79799272BA5Q47681812-A1ABD74C-68A5-461B-8D85-02FB422F0E15Q49287362-9A142E36-55F3-4DD3-87A9-FA608310B87FQ50218188-0424AA1A-8981-4874-AA76-D4E2321B831CQ52717424-45ED7447-6F3D-4855-97AF-C7F8A72F81F2Q55210356-87998408-CAEB-49FB-A4D0-7F0AA85F4CBDQ55342361-0FA03D02-CF4C-4D90-993B-6164D46BEBE2Q55455720-583BE6B1-2EE2-4730-9326-6AADEFFD11FCQ57300686-2DAB6FAD-2920-46D8-956C-B1A03A09A3AA
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biomarkers of liver cell death.
@en
type
label
Biomarkers of liver cell death.
@en
prefLabel
Biomarkers of liver cell death.
@en
P2093
P1476
Biomarkers of liver cell death.
@en
P2093
Akiko Eguchi
Alexander Wree
Ariel E Feldstein
P304
P356
10.1016/J.JHEP.2013.12.026
P577
2014-01-08T00:00:00Z